F. Moureau

发表

Synthesis and Evaluation of Bicyclic Hydroxypyridones as Inhibitors of Catechol O-Methyltransferase

J. Barrow, M. Wood, D. Swinnen, 2019, ACS medicinal chemistry letters.

Optimization of 8-Hydroxyquinolines as Inhibitors of Catechol O-Methyltransferase.

J. Barrow, M. Wood, D. Swinnen, 2018, Journal of medicinal chemistry.

Experimental and theoretical study of reversible monoamine oxidase inhibitors: structural approach of the active site of the enzyme.

J. Wouters, D. P. Vercauteren, F. Durant, 1994, Journal of neural transmission. Supplementum.

Structural and theoretical study of 5-(R)-(methoxymethyl)-3-aryl-oxazolidin-2-ones, reversible monoamine oxidase inhibitors

J. Wouters, F. Durant, M. Dőry, 1993 .

A reversible monoamine oxidase inhibitor, toloxatone: structural and electronic properties

J. Wouters, D. P. Vercauteren, F. Durant, 1992 .

Bioactive conformations of peptides and mimetics as milestones in drug design: Investigation of NK1 receptor antagonists

R. Houssin, J. Hénichart, S. Goldstein, 2004, Letters in Peptide Science.

A reversible monoamine oxidase inhibitor, Toloxatone: comparison of its physicochemical properties with those of other inhibitors including Brofaromine, Harmine, R40519 and Moclobemide

J. Wouters, D. P. Vercauteren, F. Durant, 1995 .

A reversible monoamine oxidase inhibitor, toloxatone: spectrophotometric and molecular orbital studies of the interaction with flavin adenine dinucleotide (FAD)

J. Wouters, D. P. Vercauteren, F. Durant, 1994 .

Discovery of 4-substituted pyrrolidone butanamides as new agents with significant antiepileptic activity.

M. Gillard, P. Talaga, Bénédicte Lallemand, 2004, Journal of medicinal chemistry.

A reversible monoamine oxidase A inhibitor, befloxatone: structural approach of its mechanism of action.

J. Wouters, F. Durant, S. Jegham, 1999, Bioorganic & medicinal chemistry.

Structural characterization of oxidized lumiflavin hydrochloride hydrate: Comparison with the hydrogen bonding at the cofactor of flavoproteins

B. Norberg, J. Wouters, F. Durant, 1994 .

Discovery of orally bioavailable NK1 receptor antagonists.

T. Taverne, T. Ryckmans, L. Goossens, 2003, Bioorganic & medicinal chemistry letters.

Discovery of Heterocyclic Nonacetamide Synaptic Vesicle Protein 2A (SV2A) Ligands with Single‐Digit Nanomolar Potency: Opening Avenues towards the First SV2A Positron Emission Tomography (PET) Ligands

X. Sauvage, E. Jnoff, J. Mercier, 2014, ChemMedChem.

QSAR of nortropane-substituted benzamides: use of lipophilic (RP-HPLC) and electronic (1H NMR) parameters

H. van de Waterbeemd, B. Testa, H. Waterbeemd, 1989 .

Molecular Structure Analysis of Moclobemide, a Monoamine Oxidase Inhibitor

B. Norberg, J. Wouters, F. Durant, 2010 .